T45 Labs
Michael Mandel is a seasoned professional in the medical technology sector with expansive experience in corporate development and investment banking. Currently serving as Partner and Chief Business Development Officer at T45 Labs since October 2022, Michael also holds leadership roles at VahatiCor Inc., NuevoSono, and Advanced NanoTherapies, Inc. as Head of Corporate Development since April 2022 and April 2021, respectively. As President of SAJ Advisors, Inc. since October 2010, Michael provides strategic and financial advisory services. Previous positions include Managing Director of Healthcare Investment Banking at Brean Capital, LLC and Landmark Ventures, and Director at BMO Capital Markets. Michael earned an MBA in Finance from Columbia Business School and a Bachelor of Commerce in Finance from the University of Manitoba.
This person is not in any teams
This person is not in any offices
T45 Labs
T45 Labs is a MedTech Incubator based in Silicon Valley, specializing in developing minimally invasive technologies for the cardiovascular market. Our strategy focuses on minimizing risks and maximizing returns through a fast-follower approach. We manage the T45 Fund I, a direct investment vehicle supporting Series A and Series B stages in our portfolio companies. Our team comprises experienced executives and engineers, leveraging their expertise in MedTech investments and development to drive innovation.